Jason L. Vassy on Muck Rack

Jason L. Vassy

Boston
As seen in: British Journal of Cancer, Nature, Wiley Online Library, JAMA (The Journal of the American Medical Association), JAMA Network, Science Magazine, Cell Press, Annals of Internal Medicine, Healio, Diabetes Care Magazine and
Primary care physician and genomic medicine researcher @VABostonHC | Assoc Prof @HarvardMed | @BrighamWomens | @Genomes2People
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Jason L.

Contact Jason L., search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Tu1379 COLORECTAL CANCER SCREENING UPTAKE AFTER POLYGENIC RISK SCORE DISCLOSURE: THE GENOVA STUDY

|
By Brian Sullivan, Thomas Yi, Katharine Macisaac, Charles A. Brunette, Ashley A. Antwi, Manish K. Gala, Jason L. Vassy, Katharine Macisaac, Morgan Danowski
| Gastrointestinal Endoscopy Verified
Also available on ScienceDirect
Open in Who Shared View Duplicates (401) Issue with article?

Genomic risk model to implement precision prostate cancer screening in clinical care: the ProGRESS study - Nature Cancer

|
By Jason L. Vassy, Anna M. Dornisch, Michael Gatzen, Christopher Kachulis, Niall J Lennon, Charles A. Brunette, Richard L Hauger, Kyung Lee, Julie Lynch, Kara N. Maxwell, Jenny Donovan, Richard Martin, Jyotsna Batra, Judith Clements, Rosalind A. Eeles, Jay H. Fowke, Henrik Grönberg, Yong-Jie Lu, Robert MacInnis, Luc Multigner, Susan Neuhausen, Jong Y. Park, Gyorgy Petrovics, Anna Plym, Johanna Schleutker, Karina Dalsgaard Sørensen, Paul Townsend, Ruth C Travis, Wei Zheng
| Nature Verified
Abstract Precision healthcare aims to tailor disease prevention and early detection to individual risk. Prostate cancer screening may benefit from genomics-informed approaches. We developed and validated the P-CARE model, a prostate cancer risk prediction tool combining a polygenic score, family history and genetic ancestry, using data from over 585,000 male participants in the Million Veteran Program.
Open in Who Shared Issue with article?

Opportunistic Genomic Screening for Familial Hypercholesterolemia to Improve Low-Density Lipoprotein Cholesterol: A Randomized Clinical Trial

|
By Jason L. Vassy
| JAMA Network Verified
Opportunistic Genomic Screening for Familial Hypercholesterolemia to Improve Low-Density Lipoprotein Cholesterol: A Randomized Clinical Trial Supplement 1. Trial Protocol and Statistical Analysis Plan Supplement 2. eTable 1. MVP-ROAR Study Enrollees Excluded From Per-Protocol Analyses or With Otherwise Atypical Results eTable 2. Per-Protocol Analyses of 6-Month LDL Cholesterol and Lipid-Lowering Therapy Outcomes Among MVP-ROAR Study Trial Participants eTable 3.
Open in Who Shared Issue with article?
See all 24 licensed articles (25 Total)
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified